Kay R, Lam S, Wong K S, Wang A, Ho J
Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin.
J Neurol Sci. 1994 Oct;126(1):84-7. doi: 10.1016/0022-510x(94)90098-1.
Myasthenia gravis was diagnosed in 48 patients between 1985 and 1991 in this Chinese community. Thymectomy was performed on 36 patients and the mean postoperative follow-up period was 49 months. Significant improvement was seen in 72% of the thymectomised patients, with 33% achieving complete remission. Patients with mild generalised myasthenia at presentation or those found to have thymic hyperplasia had the best prognosis. Patients with more severe symptoms or those with an underlying thymoma also responded favourably. Only patients with ocular myasthenia or those with a normal or atrophic thymus gland had no more than an even chance of gaining significant improvement. Although previous reports suggested a high prevalence of ocular myasthenia and of thymoma among Chinese myasthenic patients, the present study has found no evidence that they respond differently to thymectomy than their Western counterparts.
1985年至1991年间,该华人社区有48例患者被诊断为重症肌无力。36例患者接受了胸腺切除术,术后平均随访期为49个月。72%接受胸腺切除术的患者有显著改善,33%实现完全缓解。初诊时为轻度全身型重症肌无力的患者或胸腺增生的患者预后最佳。症状较重的患者或患有胸腺瘤的患者也有良好反应。只有眼肌型重症肌无力患者或胸腺正常或萎缩的患者获得显著改善的机会不超过50%。尽管之前的报告表明,中国重症肌无力患者中眼肌型重症肌无力和胸腺瘤的患病率较高,但本研究未发现证据表明他们对胸腺切除术的反应与西方患者不同。